Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Plos One|August 2, 2017
Correction: EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cellsHonami Takada, Ken-Ichi Imadome, Haruna Shibayama, et al.
Molecular Cancer Research : MCR|October 25, 2017
Novel YAP1 Activator, Identified by Transcription-Based Functional Screen, Limits Multiple Myeloma GrowthJunichi Maruyama, Kazutoshi Inami, Fumiyoshi Michishita, et al.
Molecular Cancer Research : MCR|July 28, 2022
Proliferation and Self-Renewal Are Differentially Sensitive to NRASG12V Oncogene Levels in an Acute Myeloid Leukemia Cell LineMorito Kurata, Marie Lue Antony, Klara E Noble-Orcutt, et al.
Plos One|March 28, 2017
EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cellsHonami Takada, Ken-Ichi Imadome, Haruna Shibayama, et al.
Blood Advances|December 12, 2018
Ablation of miR-146b in mice causes hematopoietic malignancyTakahiro Mitsumura, Yoshiaki Ito, Tomoki Chiba, et al.
Cancer Science|June 27, 2023
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritisKeisuke Tanaka, Ayako Ichikawa, Natsuka Umezawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 20, 2021
Infiltrative tumor interface with normal renal parenchyma in locally advanced renal cell carcinoma: Clinical relevance and pathological implicationsWataru Shimada, Hajime Tanaka, Yuki Fukawa, et al.
FEMS Microbiology Letters|May 21, 2009
pfaB products determine the molecular species produced in bacterial polyunsaturated fatty acid biosynthesisYoshitake Orikasa, Mika Tanaka, Shinji Sugihara, et al.
International Journal of Hematology|June 24, 2021
MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutationsShunichiro Yasuda, Satoru Aoyama, Ryoto Yoshimoto, et al.
Frontiers in Oncology|September 22, 2022
Quantitative high-throughput analysis of tumor infiltrating lymphocytes in breast cancerKumiko Hayashi, Daichi Nogawa, Maki Kobayashi, et al.
Pageof 12